{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:09:36Z","timestamp":1793171376021,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","award":["RC 2022"],"award-info":[{"award-number":["RC 2022"]}],"id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Job\u2019s syndrome, or autosomal dominant hyperimmunoglobulin E syndrome (AD-HIES, STAT3-Dominant Negative), is a rare inborn error of immunity (IEI) with multi-organ involvement and long-life post-infective damage. Longitudinal registries are of primary importance in improving our knowledge of the natural history and management of these rare disorders. This study aimed to describe the natural history of 30 Italian patients with AD-HIES recorded in the Italian network for primary immunodeficiency (IPINet) registry. This study shows the incidence of manifestations present at the time of diagnosis versus those that arose during follow up at a referral center for IEI. The mean time of diagnostic delay was 13.7\u00a0years, while the age of disease onset was\u2009&lt;\u200912\u00a0months in 66.7% of patients. Respiratory complications, namely bronchiectasis and pneumatoceles, were present at diagnosis in 46.7% and 43.3% of patients, respectively. Antimicrobial prophylaxis resulted in a decrease in the incidence of pneumonia from 76.7% to 46.7%. At the time of diagnosis, skin involvement was present in 93.3% of the patients, including eczema (80.8%) and abscesses (66.7%). At the time of follow-up, under therapy, the prevalence of complications decreased: eczema and skin abscesses reduced to 63.3% and 56.7%, respectively. Antifungal prophylaxis decreased the incidence of mucocutaneous candidiasis from 70% to 56.7%. During the SARS-CoV-2 pandemic, seven patients developed COVID-19. Survival analyses showed that 27 out of 30 patients survived, while three patients died at ages of 28, 39, and 46\u00a0years as a consequence of lung bleeding, lymphoma, and sepsis, respectively. Analysis of a cumulative follow-up period of 278.7 patient-years showed that early diagnosis, adequate management at expertise centers for IEI, prophylactic antibiotics, and antifungal therapy improve outcomes and can positively influence the life expectancy of patients.<\/jats:p>","DOI":"10.1186\/s13223-023-00776-5","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:03:34Z","timestamp":1681949014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Long term longitudinal follow-up of an AD-HIES cohort: the impact of early diagnosis and enrollment to IPINet centers on the natural history of Job\u2019s syndrome"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0717-9096","authenticated-orcid":false,"given":"Maria","family":"Carrabba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Dellepiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Cortesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Augusta","family":"Baselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarosa","family":"Soresina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Giardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Finocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Cancrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Milito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Pacillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Laura","family":"Cinicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Consolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Montin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Quinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pession","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Fabio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pignata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Pietrogrande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Badolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"issue":"5","key":"776_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s10875-021-01051-1","volume":"41","author":"C Tsilifis","year":"2021","unstructured":"Tsilifis C, Freeman AF, Gennery AR. STAT3 hyper-IgE syndrome-an update and unanswered questions. J Clin Immunol. 2021;41(5):864\u201380. https:\/\/doi.org\/10.1007\/s10875-021-01051-1.","journal-title":"J Clin Immunol"},{"issue":"16","key":"776_CR2","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa073687","volume":"357","author":"SM Holland","year":"2007","unstructured":"Holland SM, DeLeo FR, Elloumi HZ, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357(16):1608\u201319. https:\/\/doi.org\/10.1056\/NEJMoa073687.","journal-title":"N Engl J Med"},{"issue":"7445","key":"776_CR3","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/s0140-6736(66)90119-x","volume":"1","author":"SD Davis","year":"1996","unstructured":"Davis SD, Schaller J, Wedgwood RJ. Job\u2019s syndrome. Recurrent, \u201ccold\u201d, staphylococcal abscesses. Lancet. 1996;1(7445):1013\u20135. https:\/\/doi.org\/10.1016\/s0140-6736(66)90119-x.","journal-title":"Lancet."},{"issue":"1","key":"776_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1542\/peds.49.1.59","volume":"49","author":"RH Buckley","year":"1972","unstructured":"Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics. 1972;49(1):59\u201370.","journal-title":"Pediatrics"},{"issue":"7881","key":"776_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/s0140-6736(74)91942-4","volume":"2","author":"HR Hill","year":"1974","unstructured":"Hill HR, Ochs HD, Quie PG, et al. Defect in neutrophil granulocyte chemotaxis in Job\u2019s syndrome of recurrent \u201ccold\u201d staphylococcal abscesses. Lancet. 1974;2(7881):617\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(74)91942-4.","journal-title":"Lancet"},{"issue":"9","key":"776_CR6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJM199903043400904","volume":"340","author":"B Grimbacher","year":"1999","unstructured":"Grimbacher B, Holland SM, Gallin JI, et al. Hyper-IgE syndrome with recurrent infections\u2013an autosomal dominant multisystem disorder. N Engl J Med. 1999;340(9):692\u2013702. https:\/\/doi.org\/10.1056\/NEJM199903043400904.","journal-title":"N Engl J Med"},{"issue":"7157","key":"776_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/nature06096","volume":"448","author":"Y Minegishi","year":"2007","unstructured":"Minegishi Y, Saito M, Tsuchiya S, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448(7157):1058\u201362. https:\/\/doi.org\/10.1038\/nature06096.","journal-title":"Nature"},{"issue":"2","key":"776_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","volume":"125","author":"C Woellner","year":"2010","unstructured":"Woellner C, Gertz EM, Sch\u00e4ffer AA, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125(2):424-432.e8. https:\/\/doi.org\/10.1016\/j.jaci.2009.10.059.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"776_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/imcb.12209","volume":"97","author":"T Al-Shaikhly","year":"2019","unstructured":"Al-Shaikhly T, Ochs HD. Hyper IgE syndromes: clinical and molecular characteristics. Immunol Cell Biol. 2019;97(4):368\u201379. https:\/\/doi.org\/10.1111\/imcb.12209.","journal-title":"Immunol Cell Biol"},{"key":"776_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1749-6632.2011.06280.x","volume":"1246","author":"Y Minegishi","year":"2011","unstructured":"Minegishi Y, Saito M. Molecular mechanisms of the immunological abnormalities in hyper-IgE syndrome. Ann NY Acad Sci. 2011;1246:34\u201340. https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06280.x.","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"776_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1084\/jem.20091706","volume":"207","author":"DT Avery","year":"2010","unstructured":"Avery DT, Deenick EK, Ma CS, et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med. 2010;207(1):155\u201371. https:\/\/doi.org\/10.1084\/jem.20091706.","journal-title":"J Exp Med"},{"issue":"5","key":"776_CR12","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1182\/blood-2008-02-142745","volume":"112","author":"DT Avery","year":"2008","unstructured":"Avery DT, Ma CS, Bryant VL, et al. STAT3 is required for IL-21-induced secretion of IgE from human naive B cells. Blood. 2008;112(5):1784\u201393. https:\/\/doi.org\/10.1182\/blood-2008-02-142745.","journal-title":"Blood"},{"issue":"5","key":"776_CR13","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jaci.2012.09.011","volume":"130","author":"L Mar\u00f3di","year":"2012","unstructured":"Mar\u00f3di L, Cypowyj S, T\u00f3th B, et al. Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species. J Allergy Clin Immunol. 2012;130(5):1019\u201327. https:\/\/doi.org\/10.1016\/j.jaci.2012.09.011.","journal-title":"J Allergy Clin Immunol"},{"issue":"24","key":"776_CR14","doi-asserted-by":"publisher","first-page":"4956","DOI":"10.1126\/sciimmunol.aat4956","volume":"3","author":"V B\u00e9ziat","year":"2018","unstructured":"B\u00e9ziat V, Li J, Lin JX, et al. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Sci Immunol. 2018;3(24):4956. https:\/\/doi.org\/10.1126\/sciimmunol.aat4956.","journal-title":"Sci Immunol."},{"issue":"9","key":"776_CR15","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1084\/jem.20161810","volume":"214","author":"T Schwerd","year":"2017","unstructured":"Schwerd T, Twigg SRF, Aschenbrenner D, et al. A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis. J Exp Med. 2017;214(9):2547\u201362. https:\/\/doi.org\/10.1084\/jem.20161810.","journal-title":"J Exp Med"},{"issue":"3","key":"776_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1084\/jem.20161435","volume":"214","author":"JJ Lyons","year":"2017","unstructured":"Lyons JJ, Liu Y, Ma CA, et al. ERBIN deficiency links STAT3 and TGF-\u03b2 pathway defects with atopy in humans. J Exp Med. 2017;214(3):669\u201380. https:\/\/doi.org\/10.1084\/jem.20161435.","journal-title":"J Exp Med."},{"issue":"3","key":"776_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1086\/302547","volume":"65","author":"B Grimbacher","year":"1999","unstructured":"Grimbacher B, Sch\u00e4ffer AA, Holland SM, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999;65(3):735\u201344. https:\/\/doi.org\/10.1086\/302547.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"776_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","volume":"91","author":"MO Chandesris","year":"2012","unstructured":"Chandesris MO, Melki I, Natividad A, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine. 2012;91(4):e1\u201319. https:\/\/doi.org\/10.1097\/MD.0b013e31825f95b9.","journal-title":"Medicine"},{"issue":"3","key":"776_CR19","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jaip.2017.06.041","volume":"6","author":"Y Gernez","year":"2018","unstructured":"Gernez Y, Freeman AF, Holland SM, et al. Autosomal dominant hyper-IgE syndrome in the USIDNET registry. J Allergy Clin Immunol Pract. 2018;6(3):996\u20131001. https:\/\/doi.org\/10.1016\/j.jaip.2017.06.041.","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"2","key":"776_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10875-017-0369-7","volume":"37","author":"J Wu","year":"2017","unstructured":"Wu J, Chen J, Tian ZQ, et al. Clinical manifestations and genetic analysis of 17 patients with autosomal dominant hyper-IgE syndrome in Mainland China: new reports and a literature review. J Clin Immunol. 2017;37(2):166\u201379. https:\/\/doi.org\/10.1007\/s10875-017-0369-7.","journal-title":"J Clin Immunol"},{"issue":"6","key":"776_CR21","doi-asserted-by":"publisher","first-page":"e12885","DOI":"10.1111\/sji.12885","volume":"91","author":"Q Xiang","year":"2020","unstructured":"Xiang Q, Zhang L, Liu X, et al. Autosomal dominant hyper IgE syndrome from a single centre in Chongqing, China (2009\u20132018). Scand J Immunol. 2020;91(6):e12885. https:\/\/doi.org\/10.1111\/sji.12885.","journal-title":"Scand J Immunol."},{"issue":"4","key":"776_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/pai.13043","volume":"30","author":"M Tavassoli","year":"2019","unstructured":"Tavassoli M, Abolhassani H, Yazdani R, et al. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: a long-term follow-up and genetic analysis. Pediatr Allergy Immunol. 2019;30(4):469\u201378. https:\/\/doi.org\/10.1111\/pai.13043.","journal-title":"Pediatr Allergy Immunol"},{"key":"776_CR23","doi-asserted-by":"publisher","first-page":"626593","DOI":"10.3389\/fimmu.2021.626593","volume":"12","author":"B Saikia","year":"2021","unstructured":"Saikia B, Rawat A, Minz RW, et al. Clinical profile of hyper-IgE syndrome in India. Front Immunol. 2021;12:626593. https:\/\/doi.org\/10.3389\/fimmu.2021.626593.","journal-title":"Front Immunol."},{"issue":"7","key":"776_CR24","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s10875-020-00844-0","volume":"40","author":"V Lougaris","year":"2020","unstructured":"Lougaris V, Pession A, Baronio M, et al. The Italian registry for primary immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): twenty years of experience (1999\u20132019). J Clin Immunol. 2020;40(7):1026\u201337. https:\/\/doi.org\/10.1007\/s10875-020-00844-0.","journal-title":"J Clin Immunol"},{"issue":"Suppl 2","key":"776_CR25","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1038\/bmt.2008.52","volume":"41","author":"A Pession","year":"2008","unstructured":"Pession A, Rondelli R. Collection and transfer of data: the AIEOP model. Bone Marrow Transplant. 2008;41(Suppl 2):S35\u20138. https:\/\/doi.org\/10.1038\/bmt.2008.52.","journal-title":"Bone Marrow Transplant"},{"key":"776_CR26","unstructured":"Retrieved from http:\/\/www.aieop.org\/web\/wp-content\/uploads\/2018\/02\/protocollo-HIES_maggio2014.pdf."},{"issue":"5","key":"776_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/pai.12217","volume":"25","author":"P Merli","year":"2014","unstructured":"Merli P, Novara F, Montagna D, et al. Hyper IgE syndrome: anaphylaxis in a patient carrying the N567D STAT3 mutation. Pediatr Allergy Immunol. 2014;25(5):503\u20135. https:\/\/doi.org\/10.1111\/pai.12217.","journal-title":"Pediatr Allergy Immunol"},{"issue":"8","key":"776_CR28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202592","volume":"218","author":"T Asano","year":"2021","unstructured":"Asano T, Khourieh J, Zhang P, et al. Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance. J Exp Med. 2021;218(8): e20202592. https:\/\/doi.org\/10.1084\/jem.20202592.","journal-title":"J Exp Med."},{"issue":"10","key":"776_CR29","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1002\/eji.201141721","volume":"41","author":"M Giacomelli","year":"2011","unstructured":"Giacomelli M, Tamassia N, Moratto D, et al. SH2-domain mutations in STAT3 in hyper-IgE syndrome patients result in impairment of IL-10 function. Eur J Immunol. 2011;41(10):3075\u201384. https:\/\/doi.org\/10.1002\/eji.201141721.","journal-title":"Eur J Immunol"},{"issue":"2","key":"776_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.oooo.2012.04.005","volume":"114","author":"L Esposito","year":"2012","unstructured":"Esposito L, Poletti L, Maspero C, et al. Hyper-IgE syndrome: dental implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(2):147\u201353. https:\/\/doi.org\/10.1016\/j.oooo.2012.04.005.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"3","key":"776_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/14017439709058091","volume":"31","author":"L Santambrogio","year":"1997","unstructured":"Santambrogio L, Nosotti M, Pavoni G, et al. Pneumatocele complicated by fungal lung abscess in Job\u2019s\u2019s syndrome. Successful lobectomy with the aid of videothoracoscopy. Scand Cardiovasc J. 1997;31(3):177\u20139. https:\/\/doi.org\/10.3109\/14017439709058091.","journal-title":"Scand Cardiovasc J."},{"issue":"6","key":"776_CR32","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.jaip.2019.02.012","volume":"7","author":"T Lorenzini","year":"2019","unstructured":"Lorenzini T, Giacomelli M, Scomodon O, et al. Autosomal-dominant hyper-IgE syndrome is associated with appearance of infections early in life and\/or neonatal rash: evidence from the Italian cohort of 61 patients with elevated IgE. J Allergy Clin Immunol Pract. 2019;7(6):2072\u20135. https:\/\/doi.org\/10.1016\/j.jaip.2019.02.012.","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"7","key":"776_CR33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/all.12416","volume":"69","author":"AC Boos","year":"2014","unstructured":"Boos AC, Hagl B, Schlesinger A, et al. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern. Allergy. 2014;69(7):943\u201353. https:\/\/doi.org\/10.1111\/all.12416.","journal-title":"Allergy"},{"issue":"9","key":"776_CR34","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/archderm.140.9.1119","volume":"140","author":"CL Eberting","year":"2004","unstructured":"Eberting CL, Davis J, Puck JM, et al. Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol. 2004;140(9):1119\u201325. https:\/\/doi.org\/10.1001\/archderm.140.9.1119.","journal-title":"Arch Dermatol"},{"issue":"5","key":"776_CR35","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.jaci.2011.07.046","volume":"128","author":"V Sekhsaria","year":"2011","unstructured":"Sekhsaria V, Dodd LE, Hsu AP, et al. Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol. 2011;128(5):1124\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2011.07.046.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"776_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10875-015-0231-8","volume":"36","author":"AM Flinn","year":"2016","unstructured":"Flinn AM, Cant A, Leahy TR, et al. Autosomal dominant hyper IgE syndrome-treatment strategies and clinical outcomes. J Clin Immunol. 2016;36(2):107\u20139. https:\/\/doi.org\/10.1007\/s10875-015-0231-8.","journal-title":"J Clin Immunol"},{"issue":"5","key":"776_CR37","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s10875-021-00971-2","volume":"41","author":"SC Harrison","year":"2021","unstructured":"Harrison SC, Tsilifis C, Slatter MA, et al. Hematopoietic stem cell transplantation resolves the immune deficit associated with STAT3-dominant-negative hyper-IgE syndrome. J Clin Immunol. 2021;41(5):934\u201343. https:\/\/doi.org\/10.1007\/s10875-021-00971-2.","journal-title":"J Clin Immunol"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-023-00776-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-023-00776-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-023-00776-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:04:49Z","timestamp":1681949089000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-023-00776-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["776"],"URL":"https:\/\/doi.org\/10.1186\/s13223-023-00776-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1805351\/v1","asserted-by":"object"}]},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local ethics committees approved the registry protocol study (Spedali Civili of Brescia-NP2834; Fondazione IRCCS C\u00e0 Granda Ospedale Maggiore Policlinico of Milan, approval number 1180\/14). Patients or their parents in the case of minors signed informed consent for enrollment in the IPINet registry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to the IPINet Registry included consent for the use of data for research purposes and publication. The pictures in Fig.\u00a0\n                      \n                      were published with informed consent signed by the patients (informed written consent for patients\u2019 imaging publication by Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico of Milan).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or nonfinancial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}